Evidence map›Paper›PMID 35852776›Full record

ArticleClinical rheumatology2022

Rare mutations in NLRP3 and NLRP12 associated with familial cold autoinflammatory syndrome: two Chinese pedigrees.

Shirui Chen, Zhen Li, Xia Hu, Hui Zhang, Weiwei Chen, Qiongqiong Xu, Lili Tang, Huiyao Ge, Qi Zhen, Liang Yong and 6 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. [Regulatory mechanisms of post-translational modifications in inflammasome signaling: a review].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  2. Review
  3. Review
  4. Pattern Recognition by NOD-Like Receptors.Advances in experimental medicine and biology · 2025
    Review
  5. RMD open · 2023
    Review
  6. Review
  7. Dermatologic Manifestations of Noninflammasome-Mediated Autoinflammatory Diseases.JID innovations : skin science from molecules to population health · 2023
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Shirui ChenDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0003-4498-6687
Zhen LiDepartment of Dermatology, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, 014010, China.ORCID https://orcid.org/0000-0002-6237-8880
Xia HuDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0001-6124-2693
Hui ZhangDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-3000-1552
Weiwei ChenDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-9581-0502
Qiongqiong XuDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-1116-4428
Lili TangDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-5269-3297
Huiyao GeDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-4928-1777
Qi ZhenDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-8344-4461
Liang YongDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0003-3679-3084
Yafen YuDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-2138-5953
Lu CaoDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0003-2967-2831
Ruixue ZhangDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.ORCID https://orcid.org/0000-0002-5281-6330
Yong HaoDepartment of Dermatology, The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.ORCID https://orcid.org/0000-0001-8617-0243
Jihai ShiDepartment of Dermatology, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, 014010, China. sjh@btmc.edu.cn.ORCID https://orcid.org/0000-0001-6161-0863
Liangdan SunDepartment of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China. ahmusld@163.com.ORCID http://orcid.org/0000-0002-8499-5353
Ministry of Education of the People's Republic of China · CNInner Mongolia University of Science and Technology · CNAnhui University · CN

Funding

National Natural Science Foundation of China 82060571
6 · The paper itself

Abstract

Familial cold autoinflammatory syndrome (FCAS) is the mildest subtype of cryopyrin-associated periodic syndrome (CAPS) and is a rare inherited systemic autoinflammatory disease (SAID). CAPS is the consequence of a rare group of genetic disorders that are mostly reported in European and American populations, but scarcely reported in Chinese populations. NLRP3, NLRP12, PLCG2, and NLRC4 are known pathogenic genes associated with FCAS, and the aim of this study was to identify pathogenic mutations in two intact pedigrees of Chinese FCAS. We performed Sanger sequencing of genomic DNA samples from 25 affected and 32 unaffected members of the two intact pedigrees and analyzed the pathogenic mutations for their conservativeness using multiple sequence alignment tools. In addition, we reviewed previously reported pathogenic genes of FCAS and their pathogenicity classification and summarized the characteristics of different genotypes and phenotypes of FCAS. This study reported two intact FCAS pedigrees with different genotypes and phenotypes, the heterozygous mutation (p.V72M) in NLRP3 in pedigree 1 and the heterozygous mutation (p.R754H) in NLRP12 in pedigree 2. There are no reports targeting p.V72M in NLRP3 in FCAS1, and there are relatively few relevant phenotypic data on the clinical manifestations identified in previous pedigrees. Multiple sequence comparisons of NLRP3 indicate that the p.V72M mutation is highly conserved during evolution. Our study has enriched the understanding of the pathogenesis of FCAS, a rare disease especially in Asian populations. KEY POINTS: •The NLRP3 (p.V72M) variant was first discovered in the Chinese pedigree of FCAS1 •NLRP12 (p.R754H) variants are not conserved in multiple sequence alignments, but they are still co-segregated and expressed in the big Chinese diseased pedigree.

Indexed as

Cryopyrin-Associated Periodic SyndromesHereditary Autoinflammatory DiseasesChinaHumansIntracellular Signaling Peptides and ProteinsMutationNLR Family, Pyrin Domain-Containing 3 ProteinPedigreeIntracellular Signaling Peptides and ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinNLRP12 protein, humanAutoinflammatory diseasesCryopyrin-associated periodic syndromeFamilial cold autoinflammatory syndromeNLRP12NLRP3

Identifiers

PMID35852776
OpenAlexW4285794909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.